FDA panel backs Amgen copy of AbbVie arthritis drug Humira
 

FDA panel backs Amgen copy of AbbVie arthritis drug Humira
(Reuters) - Amgen Inc's cheaper version of AbbVie's top-selling arthritis drug Humira is highly similar to the original and should be approved, an advisory panel to the U.S. Food and Drug Administration concluded on Tuesday.http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...gk:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...gk:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/Ynd3wXlfdv0